Terms: = Leukemia AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Clinical Outcome
5 results:
1. Effects of polymorphic DNA genes involved in BER and caspase pathways on the clinical outcome of myeloproliferative neoplasms under treatment with hydroxyurea.
Azevedo AP; Silva SN; Reichert A; Lima F; Júnior E; Rueff J
Mol Med Rep; 2018 Dec; 18(6):5243-5255. PubMed ID: 30320340
[TBL] [Abstract] [Full Text] [Related]
2. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Köllermann J; Miller K; Schrader M
Clin Cancer Res; 2006 Sep; 12(17):5040-6. PubMed ID: 16951219
[TBL] [Abstract] [Full Text] [Related]
3. Clonal T-cell receptor gamma and delta gene rearrangements in T-cell acute lymphoblastic leukemia at diagnosis: predictor of prognosis and response to chemotherapy.
Kode J; Dudhal N; Banavali S; Advani S; Chiplunkar S
Leuk Lymphoma; 2004 Jan; 45(1):125-33. PubMed ID: 15061208
[TBL] [Abstract] [Full Text] [Related]
4. Expression of sorcin predicts poor outcome in acute myeloid leukemia.
Tan Y; Li G; Zhao C; Wang J; Zhao H; Xue Y; Han M; Yang C
Leuk Res; 2003 Feb; 27(2):125-31. PubMed ID: 12526918
[TBL] [Abstract] [Full Text] [Related]
5. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
Petersdorf EW; Kollman C; Hurley CK; Dupont B; Nademanee A; Begovich AB; Weisdorf D; McGlave P
Blood; 2001 Nov; 98(10):2922-9. PubMed ID: 11698272
[TBL] [Abstract] [Full Text] [Related]
